ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Vanda Pharmaceuticals INC.

Official 2024 U.S. DOL Form 5500 summary for Vanda Pharmaceuticals INC. (Vanda Pharmaceuticals INC. 401(k) Profit Sharing Plan · EIN 03-0491827 · PN 001): $43.16M net assets, 358 active participants, and $14.22 per $10,000 (14.22 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorVanda Pharmaceuticals INC.
Filing IdentifierVanda Pharmaceuticals INC. 401(k) Profit Sharing Plan · EIN 03-0491827 · PN 001
Plan Category & State401(k) Defined Contribution (DC)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$43.16M
Active Participants358
Direct Admin Fee Rate$14.22 per $10,000 (14.22 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI